Back to News
Market Impact: 0.25

Benjamin Graham Detailed Fundamental Analysis

ALBNDAQ
Company FundamentalsAnalyst InsightsCorporate Earnings
Benjamin Graham Detailed Fundamental Analysis

Albemarle Corporation (ALB) received a 71% rating from Validea's Benjamin Graham-based Value Investor model, falling short of the 80% threshold for 'some interest'. While ALB demonstrated strong fundamental metrics including sales, current ratio, debt management, and long-term EPS growth, it notably failed key deep value criteria such as its P/E and Price/Book ratios, indicating it does not align with a strict Graham-style value investment.

Analysis

Albemarle Corporation (ALB) scores 71% under Validea's Benjamin Graham-based Value Investor model, a rating that falls short of the 80% threshold required to signal even moderate interest from this specific deep value strategy. The analysis reveals a dichotomy in the company's profile: ALB exhibits strong underlying fundamentals, passing crucial tests for sales performance, current ratio, management of long-term debt relative to net current assets, and long-term EPS growth. However, it fails on the two cornerstone valuation metrics of the Graham methodology, the Price-to-Earnings (P/E) and Price-to-Book (P/B) ratios. This indicates that despite its operational health and status as a large-cap growth stock in the Chemical Manufacturing industry, its current market valuation is too high to qualify it as a traditional deep value investment according to these stringent criteria.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

mixed

Sentiment Score

0.00

Ticker Sentiment

ALB0.00
NDAQ0.00

Key Decisions for Investors

  • Strict value investors following a Graham-style discipline should note that ALB fails key valuation hurdles, suggesting it is not a compelling deep value opportunity at its current price.
  • Investors with a growth or GARP (Growth at a Reasonable Price) mandate may find the positive signals on sales, EPS growth, and debt management to be constructive, warranting further analysis to determine if the growth profile justifies the current valuation.
  • Portfolio managers should consider that while ALB demonstrates strong fundamental health, its classification as a value stock is contentious, making it more suitable for portfolios that are not exclusively focused on deep value strategies.